Synonyms: BMS820132 | compound 31 [PMID: 35179904]
Compound class:
Synthetic organic
Comment: BMS-820132 is an investigational oral glucokinase (hexokinase 4) partial activator that was designed for potential to treat type 2 diabetes mellitus (T2DM) [1].
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
3-[5-(azetidine-1-carbonyl)pyrazin-2-yl]oxy-N-[1-(diethoxyphosphorylmethyl)pyrazol-3-yl]-5-propan-2-yloxybenzamide |
Synonyms |
BMS820132 | compound 31 [PMID: 35179904] |
Database Links | |
GtoPdb PubChem SID | 461663487 |
PubChem CID | 58265877 |
RCSB PDB Ligand | G1S |
Search Google for chemical match using the InChIKey | OYUDYQMFVRHPIY-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | OYUDYQMFVRHPIY |
UniChem Compound Search for chemical match using the InChIKey | OYUDYQMFVRHPIY-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | OYUDYQMFVRHPIY-UHFFFAOYSA-N |